94 related articles for article (PubMed ID: 32508031)
1. Four methylation-driven genes may be prognostic biomarkers in clear cell renal carcinoma.
Yin H; Zhang H; Wang X; Xu Q
Clin Transl Med; 2020 Jun; 10(2):e45. PubMed ID: 32508031
[No Abstract] [Full Text] [Related]
2. LAT, HOXD3 and NFE2L3 identified as novel DNA methylation-driven genes and prognostic markers in human clear cell renal cell carcinoma by integrative bioinformatics approaches.
Wang J; Zhao H; Dong H; Zhu L; Wang S; Wang P; Ren Q; Zhu H; Chen J; Lin Z; Cheng Y; Qian B; Zhang Y; Jia R; Wu W; Lu J; Tan J
J Cancer; 2019; 10(26):6726-6737. PubMed ID: 31777602
[No Abstract] [Full Text] [Related]
3. Identification and Comprehensive Validation of a DNA Methylation-Driven Gene-Based Prognostic Model for Clear Cell Renal Cell Carcinoma.
Zhang D; Wang Y; Hu X
DNA Cell Biol; 2020 Oct; 39(10):1799-1812. PubMed ID: 32716214
[TBL] [Abstract][Full Text] [Related]
4. Monitoring methylation-driven genes as prognostic biomarkers in patients with lung squamous cell cancer.
Han P; Liu Q; Xiang J
Oncol Lett; 2020 Jan; 19(1):707-716. PubMed ID: 31897186
[TBL] [Abstract][Full Text] [Related]
5. Identification of methylation-driven genes related to prognosis in clear-cell renal cell carcinoma.
Wang J; Zhang Q; Zhu Q; Liu C; Nan X; Wang F; Fang L; Liu J; Xie C; Fu S; Song B
J Cell Physiol; 2020 Feb; 235(2):1296-1308. PubMed ID: 31273792
[TBL] [Abstract][Full Text] [Related]
6. Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma.
Chen G; Wang Y; Wang L; Xu W
Oncotarget; 2017 Jan; 8(3):5268-5280. PubMed ID: 28029655
[TBL] [Abstract][Full Text] [Related]
7. Integrative analysis of DNA methylation-driven genes for the prognosis of lung squamous cell carcinoma using MethylMix.
Li R; Yin YH; Jin J; Liu X; Zhang MY; Yang YE; Qu YQ
Int J Med Sci; 2020; 17(6):773-786. PubMed ID: 32218699
[No Abstract] [Full Text] [Related]
8. DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma.
Long J; Chen P; Lin J; Bai Y; Yang X; Bian J; Lin Y; Wang D; Yang X; Zheng Y; Sang X; Zhao H
Theranostics; 2019; 9(24):7251-7267. PubMed ID: 31695766
[TBL] [Abstract][Full Text] [Related]
9. [The hyper-methylated genes microRNA as potential markers of clear-cell carcinoma of kidney].
Beresneva EV; Loginov VI; Khodyrev DS; Pronina IV; Kazubskaya TP; Karpukhin AV; Braga EA; Kushlinskii NE
Klin Lab Diagn; 2017 Jan; 62(1):13-8. PubMed ID: 30615358
[TBL] [Abstract][Full Text] [Related]
10. Integrative Analysis of DNA Methylation Identified 12 Signature Genes Specific to Metastatic ccRCC.
Qian S; Sun S; Zhang L; Tian S; Xu K; Zhang G; Chen M
Front Oncol; 2020; 10():556018. PubMed ID: 33134164
[No Abstract] [Full Text] [Related]
11. ZNF492 and GPR149 methylation patterns as prognostic markers for clear cell renal cell carcinoma: Array‑based DNA methylation profiling.
Kim YJ; Jang W; Piao XM; Yoon HY; Byun YJ; Kim JS; Kim SM; Lee SK; Seo SP; Kang HW; Kim WT; Yun SJ; Shon HS; Ryu KH; Kim SW; Ha YS; Yoon GS; Lee SC; Kwon TG; Kim WJ
Oncol Rep; 2019 Jul; 42(1):453-460. PubMed ID: 31115548
[TBL] [Abstract][Full Text] [Related]
12. A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
Shi S; Ye S; Wu X; Xu M; Zhuo R; Liao Q; Xi Y
Yonsei Med J; 2019 Nov; 60(11):1013-1020. PubMed ID: 31637882
[TBL] [Abstract][Full Text] [Related]
13. An effective seven-CpG-based signature to predict survival in renal clear cell carcinoma by integrating DNA methylation and gene expression.
Xu L; He J; Cai Q; Li M; Pu X; Guo Y
Life Sci; 2020 Feb; 243():117289. PubMed ID: 31926254
[TBL] [Abstract][Full Text] [Related]
14. Novel methylation-driven genes identified as prognostic indicators for lung squamous cell carcinoma.
Li Y; Gu J; Xu F; Zhu Q; Ge D; Lu C
Am J Transl Res; 2019; 11(4):1997-2012. PubMed ID: 31105813
[TBL] [Abstract][Full Text] [Related]
15. MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma.
Fisel P; Stühler V; Bedke J; Winter S; Rausch S; Hennenlotter J; Nies AT; Stenzl A; Scharpf M; Fend F; Kruck S; Schwab M; Schaeffeler E
Oncotarget; 2015 Oct; 6(31):30615-27. PubMed ID: 26384346
[TBL] [Abstract][Full Text] [Related]
16. In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma.
Yang M; Hlady RA; Zhou D; Ho TH; Robertson KD
Cancer Med; 2019 Sep; 8(12):5760-5768. PubMed ID: 31361072
[TBL] [Abstract][Full Text] [Related]
17. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P
BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma.
Zhao E; Li L; Zhang W; Wang W; Chan Y; You B; Li X
J Transl Med; 2019 May; 17(1):177. PubMed ID: 31133033
[TBL] [Abstract][Full Text] [Related]
19. A large-scale transcriptome analysis identified ELANE and PRTN3 as novel methylation prognostic signatures for clear cell renal cell carcinoma.
Wei Z; Wu B; Wang L; Zhang J
J Cell Physiol; 2020 Mar; 235(3):2582-2589. PubMed ID: 31490025
[TBL] [Abstract][Full Text] [Related]
20. A Four-Gene Promoter Methylation Marker Panel Consisting of
van Vlodrop IJH; Joosten SC; De Meyer T; Smits KM; Van Neste L; Melotte V; Baldewijns MMLL; Schouten LJ; van den Brandt PA; Jeschke J; Yi JM; Schuebel KE; Ahuja N; Herman JG; Aarts MJ; Bosman FT; Van Criekinge W; van Engeland M
Clin Cancer Res; 2017 Apr; 23(8):2006-2018. PubMed ID: 27756787
[No Abstract] [Full Text] [Related]
[Next] [New Search]